NCT00303277View on ClinicalTrials.gov

Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Alzheimer's DiseaseAging
Interventions
DRUG

simvastatin

simvastatin 40 mg tablets once per day for 12 weeks

DRUG

pravastatin

pravastatin 80 mg tablets once per day for 12 weeks

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT00303277 - Do HMG CoA Reductase Inhibitors Affect Abeta Levels? | Biotech Hunter | Biotech Hunter